FDA Drug recall D-1425-2014
Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container…
- FDA Drug
- Class II
- terminated
- Published 2014-07-16
On 2014-07-16 the FDA classified a Class II recall of Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container… by Hospira, citing lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1425-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-06-06 |
| Published | 2014-07-16 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7793-62
Reason
Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.
Identifiers
| ndc | 0409-7793-52 |
|---|---|
| ndc | 0409-7793-62 |
| ndc | 0409-7793-13 |
| ndc | 0409-7793-23 |
| ndc | 0409-7794-52 |
| ndc | 0409-7794-62 |
| ndc | 0409-4520-02 |
| ndc | 0409-4520-30 |
| code_info | Lot # 34-811-KL, 36-106-KL, 36-114-KL; Exp. 12/15; 36-101-KL, Exp. 12/15; 37-202-KL, Exp. 1/16; 38-302-KL, Exp. 2/16; 38-305-KL, Exp. 2/16 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1425-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.